CORDIS
EU research results

CORDIS

English EN

In Silico Trial for Tuberculosis Vaccine Development

Project information

Grant agreement ID: 777123

Status

Ongoing project

  • Start date

    1 February 2018

  • End date

    31 July 2022

Funded under:

H2020-EU.3.1.5.

  • Overall budget:

    € 5 050 656,25

  • EU contribution

    € 4 549 527,50

Coordinated by:

ETNA BIOTECH SRL

Italy

Periodic Reporting for period 1 - STriTuVaD (In Silico Trial for Tuberculosis Vaccine Development)

Reporting period: 2018-02-01 to 2019-07-31

Project information

Grant agreement ID: 777123

Status

Ongoing project

  • Start date

    1 February 2018

  • End date

    31 July 2022

Funded under:

H2020-EU.3.1.5.

  • Overall budget:

    € 5 050 656,25

  • EU contribution

    € 4 549 527,50

Coordinated by:

ETNA BIOTECH SRL